Download presentation
Presentation is loading. Please wait.
Published byValentine Little Modified over 9 years ago
1
Jason Lippy, RN Paula Minor, RN University of Maryland Medical Center March 2012
2
What is ECMO? Extra Corporeal Membrane Oxygenation Blood is drained from the venous system Oxygenated through an artificial lung, removing carbon dioxide Returned to the patient
3
Goal of ECMO Ensure oxygen supply meets/exceeds the patient’s demands Prevent end organ dysfunction and tissue death. Rest heart and/or lungs Allow time for healing
4
ECMO FLOW Blood Flow 1. Deoxygenated Blood Drained from Venous Circulation 2. Blood Pump Centrimag Rotaflow 3. Membrane Oxygenator/ Heat Exchanger (Quadrox) Hollow fiber polymethylpentene 4. Oxygenated Blood Returned to the Patient 5. Pressure monitor 1 2 3 4 5
6
Venovenous (VV) ECMO Blood is drained FROM and returned TO the venous circulation Does NOT provide hemodynamic support Goal is to rest the lungs Allow time for healing
7
Venoarterial (VA) ECMO Provides pulmonary and hemodynamic support Heart and lungs are bypassed Venous/drainage and arterial/return Nonpulsatile
8
Multidisciplinary Team Critical Care Physician and/or Surgeon Attending Physician / Nurse Practitioner Bedside RN / Resource RN ECMO Specialist (RN, RT or Perfusionist) Respiratory Therapist Communication is the Key!!!
9
Pre-ECMO Management Documentation Consent, Orders, Current Type X Bedside ECMO,open chest & code cart, back-up ECMO (on unit), central line cart PRBC, heparin, NS, sedation, narcotics Pre-Procedure Are New Lines Needed? Wound Care Consult (Specialty Bed) Gastric Tube /Small Bowel Tube Placement Baseline Neuro, pulse, ECG, labs
10
VV ECMO: Two Site Cannulation 1 Drainage, 1 Return Internal Jugular Vein Femoral Vein or Saphenous Vein
11
Cannulation Dressings
12
Cannula Positions
13
Single Site Cannulation One double lumen catheter is inserted through the right IJ into the right atrium Blood is drained and returned through separate lumens in the same cannula www.avalonlabs.com
15
ECMO Considerations Based on Systems
16
Neurologic Management / Goals Brain Injury Sedation Vacation RASS 0 to -2 by Day 3 Pain Cluster Care ECMO Considerations CNS insult prior to ECMO Watch for signs of Intraventricular Hemorrhage/Infarct First 72 hours difficult sedation titration Propofol (watch Triglycerides) Precedex (brady) Narcotics
17
Cardiovascular Management / Goals Sinus rhythm MAP appropriate for age and condition Pulses (VV ECMO) Extremities ECMO Considerations Chattering Volume Deficit ECMO Flow Pulmonary HTN Right sided heart failure Vasoactive use
18
Respiratory Management / Goals Minimal Vent Settings Pulmonary Toilet Frequent Repositioning ECMO Considerations Daily Chest X-ray CO2 control ETCo2 monitor gradient “Red Rubber” suction Specialty mattress Prone
19
Respiratory ABG Patient & Arterial side of oxygenator VBG Venous side of oxygenator RECIRCULATION!!!
20
Heme Issues Appropriate HGb for the appropriate situation Remember blood can be bad Heparin bonded cannula Centrifugal pumps less damage Anticoagulation ACT (Hourly initially the your call) ○ Target 160-180 Anti Xa (q 6 hours when stable q 12) ○ Target 0.3-0.7 Platelet >50,000 Daily TEG Analysis, Plasma Free Hgb, LDH
22
22 Hemoscope TEG-Based Guidelines TEG® Value Clinical Cause Suggested Treatment R between 7 - 10 min clotting factorsx 1 FFP or 4 ml/kg R between 11-14 min clotting factorsx 2 FFP or 8 ml/kg R greater than 14 min clotting factors x 4 FFP or 16 ml/kg MA between 49 -54 mm platelet function 0.3mcg/kg DDAVP MA between 41 -48 mm platelet functionx5 platelet units MA at 40 mm or less platelet functionx10 platelet units Angle less than 45° fibrinogen level.06 u/kg cryo LY30 at 7.5% or greater, C.I. less than 3.0 Primary fibrinolysis antifibrinolytic of choice LY30 at 7.5% or greater, C.I. greater than 3.0 Secondary fibrinolysis anticoagulant of choice LY30 less than 7.5%, C.I. greater than 3.0 Prothrombotic state anticoagulant of choice
23
Gastrointestinal Management / Goals Small bowel feeding Daily Stool Gastritis Prophylaxis ECMO Considerations Bleeding Ischemia Hyper-bilirubinemia not always hemolysis
24
Renal Management / Goals Even Fluid Balance Renal protection therapy Good CI Good MBP ECMO Considerations SCUF -Hemo concentrator CRRT (prisma flex) Hyperosmomolar / hyperoncotic pH control
25
Skin Frequent Repositioning Specialty Mattress Aseptic Technique No New Sticks Wound Care Consult Edema
26
Patient and family support Must define prognosis Help MD understand family expectations Should define end-points Team communication
27
Intra Hospital Transport …Don’t Do It !! Group Effort Trial Run – scout the path Transport Team
28
The Future of ECMO
29
References Allen, S., Holena, D., McCunn, M., Kohl, B., & Sarani, B. (2011). A review of the fundamental principles and evidence base in the use of extracorporeal membrane oxygenation (ecmo) in critically ill adult patients. Journal of Intensive Care Medicine (Sage Publications Inc.), 26(1), 13-26. Retrieved from EBSCOhost. Bojar, R.M. (2011). Manual of Perioperative Care in Adult Cardiac Surgery Fifth Edition. Hoboken, NJ: Wiley-Blackwell. Gay, S., Ankney, N., Cochran, J., & Highland, K. (2005). Critical care challenges in the adult ECMO patient. Dimensions of Critical Care Nursing, 24(4), 157-164. Retrieved from EBSCOhost. Peterson, K., & Brown, M. (1990). Extracorporeal membrane oxygenation in adults: a nursing challenge. Focus on Critical Care, 17(1), 40-49. Retrieved from EBSCOhost. Santiago, M., Sanchez, A., Lopez-Herce, J., Perez, R., Del Castillo, J., Urbano, J., & Carrillo, A. (2009). The use of continuous renal replacement therapy in series with extracorporeal membrane oxygenation. Kidney International, 76(12), 1289-1292. Retrieved from EBSCOhost. Scott, L., Boudreaux, K., Thaljeh, F., Grier, L., & Conrad, S. (2004). Early enteral feedings in adults receiving venovenous extracorporeal membrane oxygenation. JPEN Journal of Parenteral & Enteral Nutrition, 28(5), 295-300. Retrieved from EBSCOhost. Short B.L., Williams, L (2010) ECMO Specialist Training Manual, Third Edition. Michigan: Extracorporeal Life Support Organization
30
References Sievert, A., Uber, W., Laws, S., & Cochran, J. (2011). Improvement in long-term ecmo by detailed monitoring of anticoagulation: a case report. Perfusion, 26(1), 59-64. doi:10.1177/0267659110385513 Van Meurs K, Lally KP, Peek G, Zwischenberger JB (2005) ECMO: Extracorporeal Cardiopulmonary Support in Critical Care, Third Edition. Michigan: Extracorporeal Life Support Organization
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.